Immatics N.V. Ordinary Shares

IMTX XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.4B

Short interest (May 15)

3.5%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.54%

↓ 1.0%

Available Shares

↓ 35.5%

Price Chart

Company Overview

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Company Info

Exchange: NASDAQ

CIK: 0001809196

Asset Type: CS

Market Data

Market Cap: $1,372,198,536

Employees: 407

Status: Active

Short Interest

Current Borrow Fee 0.54%

Range: 0.49% - 0.77%

Available Shares 2M

Range: 2.1M - 2.3M

Recent Changes

Fee Change: ↑ 6.3%

Available Change: ↑ 41.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime